Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit — New York, New York

Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Acute Treatment of Migraine, Pediatric Migraine.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit?

Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit conducted?

Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit has 2 clinical trials on record, with 2 currently active. Their work covers Acute Treatment of Migraine, Pediatric Migraine.

Is Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit accredited by Crixeo Health?

Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.